BREAKING NEWS: Japan Expects Renewable Energy to Edge Out Nuclear Power by 2030

Bloomberg - Home Search
Celgene Corp (CELG:US)
update Apr 27
114.72 -4.00 (-3.37%)
High 119.38
Low 114.31
Open 119.20
Volume 6847790
Time Apr 27
intra-day chart
High 129.06
Low 69.88
P/E 44.85
Return +60.70%
Mkt Cap 91.84 B
one year chart
Company News
Company Profile
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.